M32.1 Systemic lupus erythematosus with organ or system involvement - analogs
Description «M32.1 Systemic lupus erythematosus with organ or system involvement» | ||||||
|
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 32% Compare M32 Systemic lupus erythematosus
- 32% Compare M32.9 Systemic lupus erythematosus, unspecified
- 25% Compare L93.1 Subacute cutaneous lupus erythematosus
- 24% Compare L93.0 Discoid lupus erythematosus
- 24% Compare L93 Lupus erythematosus
- 24% Compare L93.2 Other local lupus erythematosus
- 24% Compare M32.8 Other forms of systemic lupus erythematosus
- 24% Compare I39 Endocarditis and heart valve disorders in diseases classified elsewhere
- 20% Compare I33 Acute and subacute endocarditis
- 20% Compare I33.9 Acute endocarditis, unspecified
- 20% Compare B37.6 Candidal endocarditis (I39.8*)
- 17% Compare I33.0 Acute and subacute infective endocarditis
- 17% Compare I09.1 Rheumatic diseases of endocardium, valve unspecified
- 14% Compare I01.1 Acute rheumatic endocarditis
- 12% Compare I38 Endocarditis, valve unspecified
- 12% Compare I39.8 Endocarditis, valve unspecified, in diseases classified elsewhere
- 10% Compare I25.1 Atherosclerotic heart disease
- 10% Compare I49.1 Atrial premature depolarization
- 10% Compare I08.1 Disorders of both mitral and tricuspid valves
- 10% Compare T46.0 Poisoning, cardiac-stimulant glycosides and drugs of similar action
Learn more about the selection of analogues
- Medical online service designed to help in differential diagnosis.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.